Why is Suven Life Scie. falling/rising?

As of 23-Jul, Suven Life Sciences Ltd is currently priced at 288.00, showing no change (0.00%). The stock has underperformed its sector by 0.51% today, despite being higher than the 20-day, 50-day, 100-day, and 200-day moving averages. Over the past month, the stock has experienced a significant increase of 30.82%, contributing to a year-to-date return of 123.86%. However, the company has faced challenges, including operating losses and a weak long-term fundamental strength, with net sales declining at an annual rate of -49.94% over the last five years. Additionally, the company has reported negative results for the last three consecutive quarters, which may contribute to investor concerns.
In the broader market context, the stock's recent performance contrasts with the Sensex, which has increased by 0.11% over the past week. While Suven Life Sciences has shown strong long-term performance, outperforming the BSE500 over the last three years, one year, and three months, the recent decline in institutional investor participation, which has decreased by 1.13%, raises concerns about the stock's stability. This decrease in institutional interest may indicate a lack of confidence in the company's ability to improve its financial health, especially given its negative EBITDA and falling profits despite a strong stock price increase over the past year.